-- 火曜日のブレント原油先物価格は、投資家がパキスタンでの重要な和平交渉に注目する中、停戦期限が迫る中で下落した。 ブレント原油先物価格は1%下落し、1バレル94.57ドルとなった。ムルバン原油先物は4月20日に93.04ドルで取引を終えたが、本稿執筆時点では取引されていなかった。 しかし、ドナルド・トランプ大統領が水曜夜以降の停戦延長を否定したことで、原油価格は合意への期待と新たな緊張の高まりという二者択一の状況に陥っている。 価格は月曜日の高値から下落しているものの、INGのアナリストは、エネルギー市場は現在進行中の混乱を「過小評価」している可能性があると警告し、「楽観論が供給ショックの現実を覆い隠しているようだ」と指摘した。 トランプ大統領は、合意文書に署名がない限り停戦を延長する可能性は極めて低いと述べ、イランが最終的な解決に同意するまでホルムズ海峡の米海軍による海上封鎖は継続されると改めて表明したと報じられている。 ロイター通信がイラン高官の話として報じたところによると、テヘランはイスラマバードで開催される第2回和平協議への参加を前向きに検討している。 火曜午前現在、ホルムズ海峡の船舶航行は依然として大幅に制限されている。 イランは金曜に一時的に海峡の開放を宣言したが、週末に米国がイラン船を拿捕したことを受け、再び航行制限を課した。 世界の石油供給量の約5分の1が関係するこの海域において、交渉担当者が集まると予想されるイスラマバードでの和平交渉の動向を市場は注視している。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.